Windtree Therapeutics Announces U.S. Patent Grant for Istaroxime in Acute Heart Failure Treatment  Quiver Quantitative

Unlock the Secrets of Ethical Hacking! Ready to dive into the world of offensive security? This course gives you the Black Hat hacker's perspective, teaching you attack techniques to defend against malicious activity. Learn to hack Android and Windows systems, create undetectable malware and ransomware, and even master spoofing techniques. Start your first hack in just one hour! Enroll now and gain industry-standard knowledge: Enroll Now! The healthcare-focused company will cease trading its stock on the NASDAQ by the end of the week, as its treasury strategy has not yielded results comparable to those of its industry peers.

Windtree Therapeutics Announces More Strengthening of Its Istaroxime and Next Generation SERCA2a activator Patent Estate  The Manila Times

Windtree Therapeutics has partnered with Build and Build Corporation in a $200 million deal to establish a Binance Coin (BNB) treasury. Windtree could potentially receive an additional $140 million through future subscriptions, totaling $200 million. The funding will be used to implement a BNB crypto treasury strategy, offering direct exposure to the BNB token. This aims to make Windtree the first NASDAQ-listed company to provide direct access to BNB. The initiative is intended to provide regulated access to the Binance ecosystem for both retail and institutional investors. The partnership highlights BNB's liquidity and Binance's robust ecosystem, featuring swift transactions and a thriving DeFi environment. Build and Build Corp believes this strategy addresses a critical gap in the U.S. investment landscape. Windtree's CEO emphasizes the transaction's importance, offering shareholders unique exposure to a BNB-focused treasury strategy. BNB is currently trading at $717, showing recent gains but still below its record high.

Windtree Therapeutics' CEO explains the strategy behind the biotech company's surprising $43 million apartment complex acquisition.

Windtree announces 1-for-50 reverse stock split effective Feb 20, aiming to meet Nasdaq's minimum bid requirement. Trading under adjusted basis starts Feb 21.

Using AI to find stock market opportunities. Click to read StockQuakes, by StockQuakes Team, a Substack publication with hundreds of subscribers.

BNB (BNB) price is down slightly to trade at $771 on Friday, after correcting from its new record high of $809, reached on Wednesday. The Binance exchange native token is up nearly 20% in July, amid relatively overheated market conditions and institutional adoption. 

Windtree Therapeutics (NASDAQ: WINT) has filed a national phase patent application in India for istaroxime, targeting the prevention and reduction of acute myocardial arrhythmia risks. The patent application, claiming priority to PCT/US2024/058923, focuses on treating irregular heartbeats that can affect heart pumping function.The filing is particularly significant as it covers India's population of over 1.4 billion people. The patent application is part of Windtree's strategic intellectual property plan as the company prepares for Phase 3 readiness in cardiogenic shock. The technology addresses arrhythmias in patients with heart failure and cardiomyopathy, which can be caused by underlying cardiac disease or heart failure treatments like catecholamines.

The Wind Tree is ideal for companies and communities. It reduces the carbon footprint of organizations by producing cleanly produced green energy.

Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, is pleased to announce that the United